To more closely target SARS-CoV-2 variants currently circulating in the US, the US Food and Drug Administration (FDA) authorized an updated formula of the messenger RNA (mRNA) COVID-19 vaccine, the agencyannouncedin mid-August. Under its Emergency Use Authorization, the FDA approved ...
shares of Pfizer, BioNTech and Moderna were down 0.9%, 2.0% and 6.5%, respectively. These dips in stock prices of vaccine-makers were likely due to already declining demand for COVID-19 vaccines following the end of the pandemic.
Moderna and Novavax had submitted their applications to the FDA for updating the fall 2024 season shots targeting the JN.1 strain. Novavax said it intended to make its updated vaccine available at the start of the vaccination season upon receiving FDA authorization, adding...
On October 3, 2023, FDA authorized the updated COVID-19 vaccine by Novavax for use in persons aged ≥12 years under EUA. The updated COVID-19 vaccines include a monovalent XBB.1.5 component, which is meant to broaden vaccine-induced immunity and provide protection against c...
Unlike the Pfizer-BioNTech BNTX and Moderna vaccines, which use mRNA technology, the Novavax shot triggers the immune response with a more traditional, protein-based approach. People previously vaccinated with any COVID vaccine can get one dose of the new Novavax shot, the FDA said....
Today in health care, Moderna asked the FDA to authorize its updated booster shot, but challenges remain in convincing people to get yet another COVID-19 vaccine. Welcome to Overnight Health Care, where we’re following the latest moves on policy and news affecting your health. For Th...
Moderna, Inc., a biotechnology company pioneering messenger RNA therapeutics and vaccines, and Gavi, the Vaccine Alliance, have mutually agreed to cancel remaining pending orders under the current COVID-19 vaccine supp...
Food and Drug Administration (FDA) approved updated COVID vaccines made by Pfizer and its German partner BioNTech as well as by Moderna for people ages 12 and above, and authorized them for emergency use in children ages 6 months through 11 years. Pfizer and Moderna have said shots can...
Pfizer and Moderna have said shots can roll out in coming days and the CDC said they will be available later this week. READ MORE:COVID-19 vaccine scheme for poorest has $2.6 billion left to spend Novavax's protein-based shot is still under review by the FDA and a recommendation for ...
The Pfizer-BioNTech vaccine (now Comirnaty®) was fully approved by the U.S. Food and Drug Administration (FDA) on August 23 and boosters of this shot are now available to the most vulnerable Americans.